Seek­er Bi­o­log­ics, a 5AM Ven­tures biotech led by ex-Trans­late Bio pres­i­dent, shuts down

Seek­er Bi­o­log­ics, a Boston-based biotech start­up formed out of 5AM Ven­tures to make new bi­o­log­ics, has shut down.

Seek­er set out to make new med­i­cines for au­toim­mune, al­ler­gic and in­flam­ma­to­ry dis­eases and had se­cured a Se­ries A fi­nanc­ing, ac­cord­ing to job post­ings and pro­file de­scrip­tions on LinkedIn.

“It can be chal­leng­ing to wit­ness a tal­ent­ed team ded­i­cat­ed to dis­cov­er­ing new med­i­cines fall short of their am­bi­tious goals in a de­mand­ing mar­ket. How­ev­er, sci­ence doesn’t al­ways take us in the di­rec­tion we ex­pect, nor does it ad­here to our time­line,” Jar­rat Jor­dan, VP and head of bi­ol­o­gy at Seek­er, wrote in a LinkedIn post on Thurs­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.